Predictors of developing a new need for long‐term care of older adults aged ≥70 years: Results from a population‐based cohort study in Taiwan

2019 ◽  
Author(s):  
Wei‐Chung Hsu ◽  
Jiun‐Yi Wang ◽  
Alan C Tsai
Keyword(s):  
Older Adults ◽  
Cohort Study ◽  
Long Term Care ◽  
Population Based ◽  
Term Care

Access to Psychiatrist Services for Older Adults in Long-Term Care: A Population-Based Study

2019 ◽  
Vol 20 (5) ◽  
pp. 610-616.e2 ◽  
Author(s):  
Christopher Perlman ◽  
Julia Kirkham ◽  
Clive Velkers ◽  
Roxanne H. Leung ◽  
Marlo Whitehead ◽  
...  
Keyword(s):  
Older Adults ◽  
Long Term Care ◽  
Population Based ◽  
Term Care ◽  
Population Based Study

scholarly journals The Effect of Fall Biomechanics on Risk for Hip Fracture in Older Adults: A Cohort Study of Video‐Captured Falls in Long‐Term Care

2020 ◽  
Vol 35 (10) ◽  
pp. 1914-1922 ◽  
Author(s):  
Yijian Yang ◽  
Vicki Komisar ◽  
Nataliya Shishov ◽  
Bryan Lo ◽  
Alexandra MB Korall ◽  
...  
Keyword(s):  
Older Adults ◽  
Cohort Study ◽  
Hip Fracture ◽  
Long Term Care ◽  
Term Care

Access to Psychiatrist Services for Older Adults in Long-Term Care: A Population Based Study

2016 ◽  
Vol 24 (3) ◽  
pp. S144
Author(s):  
Dallas Seitz ◽  
Julia Kirkham ◽  
Clive Velkers ◽  
Simone Vigod ◽  
Paul Kurdyak ◽  
...  
Keyword(s):  
Older Adults ◽  
Long Term Care ◽  
Population Based ◽  
Term Care ◽  
Population Based Study

scholarly journals The Decision-Making and Communication Capacities of Older Adults with Dementia: A Population-Based Study

2014 ◽  
Vol 8 (1) ◽  
pp. 17-24 ◽  
Author(s):  
Kazuko Mitoku ◽  
Setsu Shimanouchi
Keyword(s):  
Older Adults ◽  
Decision Making ◽  
Long Term Care ◽  
Population Based ◽  
Term Care ◽  
Daily Lives ◽  
People With Dementia ◽  
Decision Making Capacity ◽  
One Year

The present study assessed the decision-making and communication capacities of older adults with dementia who required assistance and care and measured the subsequent changes in these capacities. Of 845 older adults who received long-term care between April 2003 and December 2004, about half of them without dementia were excluded and the remaining 448 were finally included in the analyses. These individuals were completed follow-up for assessment for two years. The data were obtained from the Long-Term Care Insurance Certification Committee for Eligibility in Gujo City. A total of 73.7% of people with dementia were somewhat capable of making decisions (32.4% were reported as being “always capable”; 41.3% were reported as being “sometimes capable”). A total of 93.7% were somewhat capable of communicating with others (78.3% were reported as being “always capable”; 15.4% were reported as being “sometimes capable”). The results indicate that older adults with dementia can participate in their own care decisions, even if they require assistance and support in their daily lives. The present study shows, however, that baseline decision-making capacity declined to about half what they were after one year and to about one-third of what they were after two years, suggesting that earlier efforts are needed to ensure that the preferences of individuals with dementia are reflected in their care.

scholarly journals Vaccine effectiveness after 1st and 2nd dose of the BNT162b2 mRNA Covid-19 Vaccine in long-term care facility residents and healthcare workers – a Danish cohort study

2021 ◽  
Author(s):  
Ida Rask Moustsen-Helms ◽  
Hanne-Dorthe Emborg ◽  
Jens Nielsen ◽  
Katrine Finderup Nielsen ◽  
Tyra Grove Krause ◽  
...  
Keyword(s):  
Cohort Study ◽  
Healthcare Workers ◽  
Long Term Care ◽  
Care Facility ◽  
Dose Schedule ◽  
Population Based ◽  
Vaccine Effectiveness ◽  
Calendar Time ◽  
Term Care

AbstractBackgroundAt the end of 2020, Denmark launched an immunization program against SARS-CoV-2. The Danish health authorities prioritized persons currently living in long-term care facilities (LTCF residents) and frontline healthcare workers (HCW) as the first receivers of vaccination. Here we present preliminary population based vaccine effectiveness (VE) estimates in these two target groups.MethodsThe study was designed as a retrospective registry- and population-based observational cohort study including all LTCF residents and all HWC. The outcome was a polymerase chain reaction confirmed SARS-CoV-2, and VE was estimated for different periods following first and second dose. We used Poisson and Cox regressions to estimate respectively crude and calendar time-adjusted VE for the BNT162b2 mRNA Covid-19 Vaccine from Pfizer/BioNTech with 95% confidence intervals (CI) for vaccinated versus unvaccinated.ResultsA total of 39,040 LTCF residents (median age at first dose; 84 years, Interquartile range (IQR): 77-90) and 331,039 HCW (median age at first dose; 47 years, IQR: 36-57) were included. Among LTCF residents, 95.2% and 86.0% received first and second dose from 27 December 2020 until 18 February 2021, for HWC the proportion was 27.8% and 24.4%. During a median follow-up of 53 days, there were 488 and 5,663 confirmed SARS-CoV-2 cases in the unvaccinated groups, whereas there were 57 and 52 in LTCF residents and HCW within the first 7 days after the second dose and 27 and 10 cases beyond seven days of second dose. No protective effect was observed for LTCF residents after first dose. In HCW, VE was 17% (95% CI; 4-28) in the > 14 days after first dose (before second dose). Furthermore, the VE in LTCF residents at day 0-7 of second dose was 52% (95% CI; 27-69) and 46% (95% CI; 28-59) in HCW. Beyond seven days of second dose, VE increased to 64% (95% CI; 14-84) and 90% (95% CI; 82-95) in the two groups, respectively.ConclusionThe results were promising regarding the VE both within and beyond seven days of second vaccination with the BNT162b2 mRNA Covid-19 Vaccine currently used in many countries to help mitigate the global SARS-CoV-2 pandemic.Impact of the researchSo far, observational studies of the real-word effectiveness of the mRNA Vaccine BNT162b2 has been limited to the period after the administration of the first dose. This is the first report to date to present vaccine effectiveness (VE) estimates after the second BNT162b2 mRNA Covid-19 Vaccine. We estimated a VE of 52% and 46% in LTCF residents and HCW within seven days, which increased to 64% and 90% in the two groups respectively beyond seven days of immunization. These findings supports maintaining a two-dose schedule of the BNT162b2 mRNA Covid-19 Vaccine.

Sign in / Sign up

Export Citation Format

Share Document